Magnesium oxide-pyridoxine therapy for recurrent calcium oxalate calculi.

Suppr

超能文献

作者信息

Prien E L, Gershoff S F

出版信息

J Urol. 1974 Oct;112(4):509-12. doi: 10.1016/s0022-5347(17)59777-3.

DOI:10.1016/s0022-5347(17)59777-3

PMID:4414543

Abstract

摘要

相似文献

Magnesium oxide-pyridoxine therapy for recurrent calcium oxalate calculi.

J Urol. 1974 Oct;112(4):509-12. doi: 10.1016/s0022-5347(17)59777-3.

Magnesium oxide-pyridoxine therapy for recurrent urolithiasis.

Nutr Rev. 1976 Jan;34(1):18-20. doi: 10.1111/j.1753-4887.1976.tb05663.x.

Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers.

Urol Res. 1994;22(3):161-5. doi: 10.1007/BF00571844.

[Use of magnesium oxide and vitamin B6 for the prevention of oxalate urolithiasis].

Urol Nefrol (Mosk). 1987 Nov-Dec(6):12-5.

Growth studies of calcium oxalate in the presence of various ions and compounds.

Br J Urol. 1969 Apr;41(2):171-8. doi: 10.1111/j.1464-410x.1969.tb09919.x.

[Prophylactic treatment of oxalate calculi].

Z Urol Nephrol. 1965 Jul;58(7):507-12.

[Drug therapy in urinary calculi. II. Peroral litholysis and prevention].

Urol Int. 1972;27(3):230-44. doi: 10.1159/000279785.

Calcium oxalate renal stones.

Annu Rev Med. 1975;26:173-9. doi: 10.1146/annurev.me.26.020175.001133.

Urine composition in patients with urolithiasis during treatment with magnesium oxide.

Urol Res. 1980;8(4):197-206. doi: 10.1007/BF00256993.

Effect of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones.

Am J Clin Nutr. 1967 May;20(5):393-9. doi: 10.1093/ajcn/20.5.393.

引用本文的文献

Systematic review of pharmacological, complementary, and alternative therapies for the prevention of calcium oxalate stones.

Asian J Urol. 2025 Apr;12(2):169-188. doi: 10.1016/j.ajur.2024.04.006. Epub 2024 Jul 4.

Pathophysiology and Main Molecular Mechanisms of Urinary Stone Formation and Recurrence.

Int J Mol Sci. 2024 Mar 6;25(5):3075. doi: 10.3390/ijms25053075.

The effectiveness of citrates and pyridoxine in the treatment of kidney stones.

J Med Life. 2023 Jun;16(6):856-861. doi: 10.25122/jml-2023-0234.

The current status of preventive measures for urinary calculi in children.

Ther Adv Urol. 2021 Aug 14;13:17562872211039581. doi: 10.1177/17562872211039581. eCollection 2021 Jan-Dec.

Bioavailability of magnesium from different pharmaceutical formulations.

Urol Res. 2011 Apr;39(2):123-7. doi: 10.1007/s00240-010-0309-y. Epub 2010 Sep 23.

Effect of blind treatment on stone disease.

Urol Res. 2010 Jun;38(3):205-9. doi: 10.1007/s00240-009-0244-y. Epub 2009 Dec 8.

Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers.

Urol Res. 1994;22(3):161-5. doi: 10.1007/BF00571844.

Kidney stones.

West J Med. 1980 Apr;132(4):313-32.

Urine composition in patients with urolithiasis during treatment with magnesium oxide.

Urol Res. 1980;8(4):197-206. doi: 10.1007/BF00256993.

Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones.

Int Urol Nephrol. 1988;20(4):353-9. doi: 10.1007/BF02549567.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验